Effects of antipsychotics with diverse dopamine D2 and serotonin 5-HT1A properties on cerebral dopamine and serotonin levels in rats

被引：0
|
作者：
Assié, M
Ravailhe, V
Faucillon, V
Newman-Tancredi, A
机构：
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S438 / S438
页数：1
相关论文
共 50 条
  • [1] Effects on plasma prolactin and corticosterone levels of antipsychotics with diverse dopamine D2 and serotonin 5-HT1A properties
    Carilla-Durand, E
    Assié, M
    Maraval, M
    Newman-Tancredi, A
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S438 - S438
  • [2] Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties
    Adrian Newman-Tancredi
    Mark S. Kleven
    Psychopharmacology, 2011, 216 : 451 - 473
  • [3] Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties
    Newman-Tancredi, Adrian
    Kleven, Mark S.
    PSYCHOPHARMACOLOGY, 2011, 216 (04) : 451 - 473
  • [4] Dopamine D2 and serotonin 5-HT1A receptor interaction in the context of the effects of antipsychotics - in vitro studies
    Lukasiewicz, Sylwia
    Blasiak, Ewa
    Szafran-Pilch, Kinga
    Dziedzicka-Wasylewska, Marta
    JOURNAL OF NEUROCHEMISTRY, 2016, 137 (04) : 549 - 560
  • [5] In vivo pharmacology of novel antipsychotics with diverse dopamine D2 and serotonin 5-HT1A properties: Evidence for lowered EPS liability
    Kleven, MS
    Barret-Grevoz, C
    Newman-Tancredi, A
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S437 - S437
  • [6] Dopamine D2 and serotonin 5-HT1A receptors of the brain in processing of pain
    Pertovaara, A.
    Martikainen, I. K.
    Hagelberg, N.
    Hirvonen, J.
    Scheinin, H.
    Hietala, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S113 - S113
  • [7] Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity:: comparison with typical and atypical conventional antipsychotics
    Bardin, Laurent
    Auclair, Agnes
    Kleven, Mark S.
    Prinssen, Eric P. M.
    Koek, Wouter
    Newman-Tancredi, Adrian
    Depoortre, Ronan
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 (02): : 103 - 118
  • [8] Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D2 and 5-HT1A receptors
    Clinckers, R
    Smolders, I
    Meurs, A
    Ebinger, G
    Michotte, Y
    JOURNAL OF NEUROCHEMISTRY, 2004, 89 (04) : 834 - 843
  • [9] Bifeprunox: a novel antipsychotic agent with partial agonist properties at dopamine D2 and serotonin 5-HT1A receptors
    Wadenberg, Marie-Louise G.
    FUTURE NEUROLOGY, 2007, 2 (02) : 153 - 165
  • [10] Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors
    Glennon, RA
    Dukat, M
    Grella, B
    Hong, SS
    Costantino, L
    Teitler, M
    Smith, C
    Egan, C
    Davis, K
    Mattson, MV
    DRUG AND ALCOHOL DEPENDENCE, 2000, 60 (02) : 121 - 132
12345